Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life
Radiotherapy & Oncology Aug 21, 2017
Hawkins PG, et al. – In this study, how sparing all salivary glands affected patient–reported outcome measures (PROMs), was explored. PROMs were maximized by reducing doses to all salivary glands. In addition, failure risk was not increased by a contralateral submandibular gland (cSMG) dose constraint of ≤39 G.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
